Stem Cell Therapy for Cholestasis: Ein Überblick
Cholestasis, a condition characterized by impaired bile flow, can lead to liver damage and fibrosis. Current treatment options are limited and often ineffective. Stammzelltherapie has emerged as a promising approach for cholestasis treatment, Bieten des Potenzials für Geweberegeneration und funktionelle Wiederherstellung.
Current Challenges in Cholestasis Treatment
Conventional cholestasis treatments, such as ursodeoxycholic acid and cholestyramine, provide symptomatic relief but do not address the underlying cause. Liver transplantation is the only curative option for end-stage cholestasis, but it is limited by donor availability and the risk of complications.
Stem Cells as a Potential Therapeutic Option
Stem cells possess the ability to self-renew and differentiate into various cell types. Their regenerative potential makes them an attractive therapeutic option for cholestasis, where damaged liver cells can be replaced or repaired. Stammzellen können aus verschiedenen Quellen abgeleitet werden, einschließlich Knochenmark, Fettgewebe, und Nabelschnurblut.
Types of Stem Cells for Cholestasis Treatment
Different types of stem cells have been investigated for cholestasis treatment. Mesenchymale Stammzellen (MSCs) are multipotent cells that can differentiate into various cell types, einschließlich Leberzellen. Hepatic stem cells (HSCs) are liver-specific stem cells that can regenerate liver tissue. Embryonale Stammzellen (Escs) are pluripotent cells that can differentiate into any cell type in the body.
